Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-14
2007-08-14
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S106000, C544S111000, C544S141000, C544S143000, C544S224000, C544S336000, C544S359000, C544S373000, C546S268100, C546S276400, C546S277400, C548S452000, C548S465000, C514S231200, C514S233500, C514S254010, C514S339000
Reexamination Certificate
active
10477795
ABSTRACT:
The present invention relates to compounds of formula I which are antagonists of gonadotropin releasing hormone (GnRH) activity. The invention also relates to pharmaceutical formulations, the use of a compound of the present invention in the manufacture of a medicament, a method of therapeutic treatment using such a compound and processes for producing the compounds
REFERENCES:
patent: 5580957 (1996-12-01), Hoeger et al.
patent: 5756507 (1998-05-01), Goulet et al.
patent: 6809098 (2004-10-01), Wardleworth et al.
patent: 97/21704 (1997-06-01), None
patent: 97/21707 (1997-06-01), None
patent: WO-97/21435 (1997-06-01), None
patent: WO-97/21703 (1997-06-01), None
patent: 98/55116 (1998-12-01), None
patent: 98/55119 (1998-12-01), None
patent: 98/55123 (1998-12-01), None
patent: 98/55470 (1998-12-01), None
patent: 98/55479 (1998-12-01), None
patent: 99/21557 (1999-05-01), None
patent: WO-99/21553 (1999-05-01), None
patent: 99/41251 (1999-08-01), None
patent: 99/41252 (1999-08-01), None
patent: 99/51231 (1999-10-01), None
patent: 99/51232 (1999-10-01), None
patent: 99/51233 (1999-10-01), None
patent: 99/51234 (1999-10-01), None
patent: 99/51595 (1999-10-01), None
patent: 99/51596 (1999-10-01), None
patent: 00/04013 (2000-01-01), None
patent: 00/53178 (2000-09-01), None
patent: 00/53179 (2000-09-01), None
patent: 00/53180 (2000-09-01), None
patent: 00/53181 (2000-09-01), None
patent: 00/53185 (2000-09-01), None
patent: 00/53602 (2000-09-01), None
patent: 00/69433 (2000-11-01), None
patent: WO-02/066459 (2002-08-01), None
Chu, L., et al., “Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles,” Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 11, No. 4, 509-513 (Feb. 26, 2001) XP004230047.
Chu, L., et al., “SAR studies of novel 5-substituted 2-arylindoles as nonpeptidyl GnRH receptor antagonists,” Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 11, No. 4, 515-517 (Feb. 26, 2001) XP004230048.
Lin, P., et al., “Heterocyclic Derivatives of 2-(3,5-Dimethylphenyl)tryptamine as GnRH Receptor Antagonists,” Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 11, No. 8, 1077-1080 (Apr. 23, 2001) XP002217298.
Simeone, J.P., et al., “Modification of the Pyridine Moiety of Non-peptidyl Indole GnHR Receptor Antagonists,” Bioorganic & Medicinal Chemistry Letters, 12, 3329-3332 (2002).
Ujjainwalla F., et al., “Total synthesis of 6- and 7-azaindole derived GnHR antagonists,” Tetrahedron Letters 42, 6441-6445 (2001).
Gibbs, J.B., et al., “Pharmaceutical Research in Molecular Oncology,” Cell, 79(2), 193-198 (1994).
Ashton, W.T., Substituted Indole-5-carboxamides and -acetamides as Potent Nonpeptide GnRH Receptor Antagonist, Bioorganic & Medicinal Chemistry Letters, 2001, 1723-1726, vol. 11.
Ashton et. al., Potent Nonpeptide GnHR Receptor Antagonists Derived from Substituted Indole-5-carboxamides and -acetamides Bearing a Pyridine Side-Chain Terminus, Bioorganic & Medicinal Chemistry Letters, 2001, 1727-1731, vol. 11.
Ashton et. al., Orally Bioavailable, Indole-Based Nonpeptide GnHR Receptor Antagonists with High Potency and Functional Activity, Bioorganic and Medicinal Chemistry Letters, 2001, 2597-2602, vol. 11.
Freidinger, R. M., Nonpeptidic ligands for peptide and protein receptors, Current Opinion in Chemical Biology, 1999, 395-406, vol. 3.
Goulet, M. T., Gonadotropin Releasing Hormone Antagonists, Annual Reports in Medicinal Chemistry, 1995, 169-178, vol. 30.
Lin, P. et al., 2-(3,5-Dimethylphenyl)tryptamine Derivatives That Bind to the GnHR Receptor, Bioorganic & Medicinal Chemistry Letters, 2001, 1073-1076, vol. 11.
Simoene et. al., Synthesis of chiral B-methyl tryptamine-derived GnHR antagonists, Tetrahedron Letters, 2001, 6459-6461, vol. 42.
Walsh et. al., A convergent synthesis of (S)-B-methyl-2-aryltryptamine based gonadotropin releasing hormone antagonists, Tetrahedron, 2001, 5233-5241, vol. 57.
Young et. al., 2-Arylindoles as Gonadotropin Releasing Hormone (GnHR) Antagonists: Optimization of the Tryptamine Side Chain, Bioorganic & Medicinal Chemistry Letters, 2002, 827-832, vol. 12.
Dossetter Alexander Graham
Halsall Christopher Thomas
Wardleworth Michael
AstraZeneca AB
Shameem Golam M. M.
LandOfFree
3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3840270